Trandolapril and Verapamil Hydrochloride recall: Subpotent
Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals…
Why was Trandolapril and Verapamil Hydrochloride recalled?
Subpotent: Out of Specification for Assay Test at the 3-month time point.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Batch # 19224744
- Product
- Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals…
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
- Quantity
- 1,200 bottles
- Distribution
- nationwide in the U.S.
- Recall date
- August 30, 2023
- Classification
- Class III
- Status
- Ongoing
- Agency
- FDA (drug)